Hoopmann M - Search Results

1

Serological and immunohistochemical HER-2/neu statuses do not correlate and lack prognostic value for ovarian cancer patients.

Hoopmann M, Sachse K, Valter MM, Becker M, Neumann R, Ortmann M, Göhring UJ, Thomas A, Mallmann P, Schöndorf T. Hoopmann M, et al. Eur J Cancer Care (Engl). 2010 Nov;19(6):809-15. doi: 10.1111/j.1365-2354.2009.01112.x. Eur J Cancer Care (Engl). 2010. PMID: 20105224

2

Immunohistochemical analysis reveals a protective effect of H-ras expression mediated via apoptosis in node-negative breast cancer patients.

Schondorf T, Rutzel S, Andrack A, Becker M, Hoopmann M, Breidenbach M, Gohring UJ. Schondorf T, et al. Among authors: hoopmann m. Int J Oncol. 2002 Feb;20(2):273-7. Int J Oncol. 2002. PMID: 11788888

3

Serologic concentrations of HER-2/neu in breast cancer patients with visceral metastases receiving trastuzumab therapy predict the clinical course.

Schöndorf T, Hoopmann M, Warm M, Neumann R, Thomas A, Göhring UJ, Eisberg C, Mallmann P. Schöndorf T, et al. Among authors: hoopmann m. Clin Chem. 2002 Aug;48(8):1360-2. Clin Chem. 2002. PMID: 12142395 No abstract available.

4

Tumor M2 pyruvate kinase--determination in breast cancer patients receiving trastuzumab therapy.

Hoopmann M, Warm M, Mallmann P, Thomas A, Göhring UJ, Schöndorf T. Hoopmann M, et al. Cancer Lett. 2002 Dec 10;187(1-2):223-8. doi: 10.1016/s0304-3835(02)00404-4. Cancer Lett. 2002. PMID: 12359372

5

Cisplatin, doxorubicin and paclitaxel induce mdr1 gene transcription in ovarian cancer cell lines.

Schöndorf T, Neumann R, Benz C, Becker M, Riffelmann M, Göhring UJ, Sartorius J, von König CH, Breidenbach M, Valter MM, Hoopmann M, Di Nicolantonio F, Kurbacher CM. Schöndorf T, et al. Among authors: hoopmann m. Recent Results Cancer Res. 2003;161:111-6. doi: 10.1007/978-3-642-19022-3_10. Recent Results Cancer Res. 2003. PMID: 12528803

6

Time to progression is dependent on the expression of the tumour suppressor PTEN in ovarian cancer patients.

Schöndorf T, Göhring UJ, Roth G, Middel I, Becker M, Moser N, Valter MM, Hoopmann M. Schöndorf T, et al. Among authors: hoopmann m. Eur J Clin Invest. 2003 Mar;33(3):256-60. doi: 10.1046/j.1365-2362.2003.01116.x. Eur J Clin Invest. 2003. PMID: 12641545

7

HER-2/neu determination in blood plasma of patients with HER-2/neu overexpressing metastasized breast cancer: a longitudinal study.

Hoopmann M, Neumann R, Tanasale T, Schöndorf T. Hoopmann M, et al. Anticancer Res. 2003 Mar-Apr;23(2A):1031-4. Anticancer Res. 2003. PMID: 12820343

8

Recurrence of breast cancer in the donor site after latissimus dorsi flap.

Hoopmann M, Warm M, Schöndorf T, Possover M, Mallmann PK. Hoopmann M, et al. Plast Reconstr Surg. 2003 Sep;112(3):819-21. doi: 10.1097/01.PRS.0000070187.46164.5A. Plast Reconstr Surg. 2003. PMID: 12960863 No abstract available.

9

Chemopersistent early recurrence in the perineal tear scar of an intrapartally diagnosed cervical cancer.

Hoopmann M, Valter M, Kurbacher C, Possover M, Mallmann PK. Hoopmann M, et al. Gynecol Oncol. 2003 Oct;91(1):272-4. doi: 10.1016/s0090-8258(03)00475-x. Gynecol Oncol. 2003. PMID: 14529694

10

Expression of the tumor suppressor gene PTEN is not altered in the progression of ovarian carcinomas and does not correlate with p27Kip1 expression.

Schöndorf T, Hoopmann M, Eversheim B, Valter MM, Becker M, Wappenschmidt B, Göhring UJ, Kübler T, Schmutzler RK, Schäfer R. Schöndorf T, et al. Among authors: hoopmann m. Oncol Rep. 2003 Nov-Dec;10(6):1717-22. Oncol Rep. 2003. PMID: 14534684

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

242 results

Search Page

Filters